UNSPSC 51411601: Suloctidil

This classification denotes a vasodilator agent with the molecular formula C20H35NOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XV1N1XY17K, chemically known as (r*,s*)-4-(isopropylthio)-alpha-(1-(octylamino)ethyl)benzyl alcohol but generally known as suloctidil, which bears US NIH Compound Identifier 5354. European Medicines Agency schedules Suloctidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10752MIG.

UNSPSC 51411601 Suloctidil is a Commodity code representing a single pharmaceutical product line. State and local governments procure suloctidil and related advanced life support medications through emergency services departments, health and human services agencies, and cooperative purchasing alliances. Recent solicitations show demand concentrated in fire rescue and emergency medical services supply chains, where these medications are stocked for emergency response. The City of Tampa's Fire Rescue department, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the mix of issuing bodies — municipal emergency services, state health agencies, and interstate cooperative purchasing vehicles — that actively source under this code. Scope focuses on securing reliable supply of medications meeting strict expiration and quality standards, with vendors required to maintain inventory freshness, rapid delivery capacity, and regulatory compliance including Safety Data Sheets and Good Manufacturing Practices certification.

The code shows recent activity across Florida, Texas, and Minnesota through cooperative purchasing channels. The City of Tampa issued IFB No. 26P00188 on April 24, 2026 (due April 8, 2026) for Advanced Life Support Medications to supply epinephrine, adenosine, labetalol, and diltiazem to Tampa Fire Rescue, with an estimated contract value of $40,000.00 and a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs and vendor capabilities for pharmacy benefit management. The Minnesota Department of Administration's MMCAP cooperative posted RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026 and a two-year initial term. Vendors must maintain relationships with authorized wholesalers including AmerisourceBergen (Cencara), Cardinal Health, and Morris & Dickson Co., LLC, and demonstrate compliance with cGMP, Drug Supply Chain Security Act certification, and minimum insurance coverage of $5,000,000 commercial general liability per occurrence.